ECAT NYSE Week ended 24 Jul 2026

Weekly Investor Report

BlackRock ESG Capital Allocation Trust · Financial Services · Asset Management

Open interactive chart View report data
Latest close 15.05 USD
-1.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 4.9% above the Trend Line and sits at 77.1% of its 52-week range. The latest completed week returned -1.7%, after a -0.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 56 out of 100
Latest Close 15.05 USD 24 Jul 2026
1W Return -1.7% latest completed week
4W Return -0.0% short-term follow-through
12W Return 5.2% quarterly tape
Trend Breadth 78.8% 41 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 10-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.7% Latest completed week; four-week move -0.0%. Indicator stack 78/67 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 51 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.9% above the Trend Line and sits at 77.1% of its 52-week range. The latest completed week returned -1.7%, after a -0.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9512-week average 0.66

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.0% over four weeks, 5.2% over 12 weeks, and 12.2% over one year. The current trend has remained active for 10 consecutive weeks.

Performance by holding period

1W-1.7%
4W-0.0%
12W5.2%
26W6.4%
52W12.2%
Active trend streak10 weeks
Active weeks in one year41
Trend breadth78.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.89Latest activity-pressure read.
Pressure change9.6%Four-week change in activity pressure.
Leadership-1.48Latest relative-leadership reading.
RS change-256.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 74%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength92/100Blend of value, momentum, and quality. Underlying universe rank 9; rank 1 is best.
Value95/100Relative valuation strength. Underlying universe rank 6; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum35/100Medium-term price momentum. Underlying universe rank 66; rank 1 is best.
Growth36/100Revenue and earnings growth. Underlying universe rank 65; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
7.0x
Price divided by trailing earnings.
Price / sales
6.9x
Market value relative to trailing revenue.
EV / EBITDA
7.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
23.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
100.0%
Gross profit retained from each unit of revenue.
Operating margin
98.7%
Operating profit retained from revenue.
Free-cash-flow margin
159.4%
Free cash flow generated from revenue.
Return on invested capital
10.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
22.2%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
22.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity1 / 19

1 acquisitions and 19 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 51 relevant articles.

7 positive · 34 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.5%Distance below the 52-week high.
13-week volatility1.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+7.1%Week of 10 Apr.
Worst week-3.6%Week of 6 Mar.
Latest week-1.7%Week of 24 Jul.

Shape of recent returns

Strong gains1
Modest gains13
Flat weeks0
Modest losses12
Sharp losses0
Recent vol1.6%13-week weekly-return volatility.
Base vol1.9%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew1.7% / -1.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape57/100

Trend, activity pressure, participation, and risk combine to a 57/100 tape read.

 Indicator analysis65/100

Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 1/12.

Activity pressure 0.95; 2 reversal markers Factors79/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 62; Small Cap Core rank 8 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 51 relevant articles.

How Blackrock Esg Capital Allocation Term Trust Shs Ben Int (ECAT) Affects Rotational Strategy Timing Insiders1 / 19

1 acquisitions and 19 disposals in the latest 180-day insider tape.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202615.05 USD-1.7%14.35 USD12.13 USD0.89-1.482.2MOn
17 Jul 202615.31 USD-1.7%14.31 USD12.09 USD1.02-0.452.7MOn
10 Jul 202615.58 USD0.3%14.27 USD12.06 USD0.91-0.342.1MOn
3 Jul 202615.53 USD3.2%14.21 USD12.01 USD0.900.632.4MOn
26 Jun 202615.05 USD-1.0%14.16 USD11.97 USD0.81-0.421.9MOn
19 Jun 202615.20 USD1.2%14.12 USD11.94 USD0.90-1.891.6MOn
12 Jun 202615.01 USD-0.5%14.07 USD11.90 USD0.92-2.303.0MOn
5 Jun 202615.09 USD-1.7%14.03 USD11.86 USD0.89-1.332.6MOn
29 May 202615.36 USD1.5%13.99 USD11.82 USD0.84-2.202.3MOn
22 May 202615.13 USD2.2%13.95 USD11.78 USD0.70-2.351.8MOn
15 May 202614.81 USD1.5%13.92 USD11.74 USD0.49-3.703.0MOff
8 May 202614.58 USD1.9%13.88 USD11.70 USD0.20-5.072.7MOff
1 May 202614.31 USD1.2%13.86 USD11.66 USD-0.08-4.822.7MOff
24 Apr 202614.15 USD0.2%13.85 USD11.63 USD-0.45-5.202.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.